DK0941108T3 - Sårheling og behandling af fibrose - Google Patents

Sårheling og behandling af fibrose

Info

Publication number
DK0941108T3
DK0941108T3 DK97947761T DK97947761T DK0941108T3 DK 0941108 T3 DK0941108 T3 DK 0941108T3 DK 97947761 T DK97947761 T DK 97947761T DK 97947761 T DK97947761 T DK 97947761T DK 0941108 T3 DK0941108 T3 DK 0941108T3
Authority
DK
Denmark
Prior art keywords
fibrosis
treatment
wound healing
compound
gelsolin
Prior art date
Application number
DK97947761T
Other languages
English (en)
Inventor
Mark William James Ferguson
Sharon O'kane
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625148.3A external-priority patent/GB9625148D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK0941108T3 publication Critical patent/DK0941108T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK97947761T 1996-12-04 1997-12-04 Sårheling og behandling af fibrose DK0941108T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625148.3A GB9625148D0 (en) 1996-12-04 1996-12-04 Wound healing
US3211596P 1996-12-05 1996-12-05
PCT/GB1997/003243 WO1998024465A1 (en) 1996-12-04 1997-12-04 Wound healing and treatment of fibrosis

Publications (1)

Publication Number Publication Date
DK0941108T3 true DK0941108T3 (da) 2002-11-18

Family

ID=26310539

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97947761T DK0941108T3 (da) 1996-12-04 1997-12-04 Sårheling og behandling af fibrose

Country Status (11)

Country Link
US (2) US20020103112A1 (da)
EP (1) EP0941108B1 (da)
JP (1) JP2001505219A (da)
AT (1) ATE226084T1 (da)
AU (1) AU744750B2 (da)
CA (1) CA2274002A1 (da)
DE (1) DE69716460T2 (da)
DK (1) DK0941108T3 (da)
ES (1) ES2183220T3 (da)
PT (1) PT941108E (da)
WO (1) WO1998024465A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255286T3 (es) * 1998-08-13 2006-06-16 HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. Inhibicion de los procesos patogenicos relacionados con las lesiones del tejido.
EP1270044A3 (en) * 2001-06-18 2003-03-12 Pfizer Limited Wound healing biomarkers
US7301020B2 (en) * 2003-06-19 2007-11-27 Wisconsin Alumni Research Foundation Macrolide analogs and methods for identifying same
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
US20070238655A1 (en) * 2003-11-12 2007-10-11 The Trustees Of The University Of Pennsylvania Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
CN1980694B (zh) * 2004-05-12 2012-09-26 布赖汉姆妇女医院有限公司 凝溶胶蛋白治疗感染的用途
AU2006308431B2 (en) * 2005-10-25 2011-11-10 Adelaide Research & Innovation Pty Ltd Methods and compositions for modulating wound repair
EP1945256B1 (en) * 2005-10-25 2012-07-04 Women's & Children's Health Research Institute Methods and compositions for improving wound repair
JP2009530613A (ja) * 2006-03-15 2009-08-27 ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレイテッド 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用
US8198094B2 (en) 2006-03-15 2012-06-12 The Brigham And Women's Hospital, Inc. Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
EP2708603B1 (en) 2008-01-25 2017-04-19 The General Hospital Corporation Diagnostic and therapeutic uses of gelsolin in renal failure
GB201003652D0 (en) * 2010-03-05 2010-04-21 Univ Cardiff Molecular target for healing or treating wounds
DK2654793T3 (da) * 2010-12-21 2017-12-18 Leidos Inc Fremgangsmåder og sammensætninger til sårbehandling.
CN118806900B (zh) * 2024-06-21 2025-09-05 中山大学附属第一医院 抑制capg活性的物质在制备治疗肾损伤所致肾脏纤维化的产品中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
EP0280560B1 (en) 1987-02-27 1994-05-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Membrane structure coated with low pI protein and methods of making and using
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
ES2124702T3 (es) 1990-04-11 1999-02-16 Brigham & Womens Hospital Usos terapeuticos de compuestos que se unen a actina.
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
WO1993004164A1 (en) 1991-08-26 1993-03-04 THE STATE OF OREGON acting by and through THE STATE OF BOARD OF HIGHER EDUCATION on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines

Also Published As

Publication number Publication date
US20020103112A1 (en) 2002-08-01
US20070087969A1 (en) 2007-04-19
PT941108E (pt) 2003-01-31
EP0941108B1 (en) 2002-10-16
DE69716460D1 (de) 2002-11-21
DE69716460T2 (de) 2003-06-26
JP2001505219A (ja) 2001-04-17
EP0941108A1 (en) 1999-09-15
AU5401098A (en) 1998-06-29
ES2183220T3 (es) 2003-03-16
WO1998024465A1 (en) 1998-06-11
CA2274002A1 (en) 1998-06-11
ATE226084T1 (de) 2002-11-15
AU744750B2 (en) 2002-02-28
US7566446B2 (en) 2009-07-28
HK1025732A1 (en) 2000-11-24

Similar Documents

Publication Publication Date Title
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
PT941108E (pt) Cicatrizacao de feridas e tratamento da fibrose
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
FI956113A7 (fi) Fungisidisia vaikuttavien aineiden yhdistelmiä
FI924451A7 (fi) Laite parannetun kudoshajoittamisen ja/tai hemostasian aikaansaamiseks i
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
FI952033A7 (fi) Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset
FI950616A7 (fi) Farmaseuttisesti aktiiviset diketopiperatsiinit
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
FI952900A7 (fi) Polypeptidi ja siitä valmistettu anti-HIV-aine
DK0871473T3 (da) Anvendelse af IL-10 til sårheling med reduceret ardannelse
DK0711140T3 (da) Antimykotisk opløsning til negle
FI961437L (fi) Vaikuttavan aineen luovuttava systeemi
DE4494827D2 (de) Aktiver Schalldämpfer
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
BG100248A (bg) Инхибитори на скваленсинтетаза
ES2152315T3 (es) Xamoneline tartrato.
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
NO960308D0 (no) Terapeutisk aktive benzoksaziner og benzotioanoner
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
BR9304388A (pt) Composição terapêutica de uso nasal
GB9306974D0 (en) Biologically and therapeutically active agents against hiv-1